Home/Filings/4/0001387131-19-007990
4//SEC Filing

Milligan John C.K. IV 4

Accession 0001387131-19-007990

CIK 0000025743other

Filed

Oct 28, 8:00 PM ET

Accepted

Oct 29, 5:03 PM ET

Size

6.9 KB

Accession

0001387131-19-007990

Insider Transaction Report

Form 4
Period: 2019-10-25
Milligan John C.K. IV
DirectorPresident, Secretary, Director10% Owner
Transactions
  • Purchase

    Common Stock

    2019-10-25$2.75/sh+72,000$198,0001,544,419 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    3,582,373
  • Common Stock

    (indirect: See Footnote)
    434,814
Footnotes (3)
  • [F1]Represents a purchase from the underwriters in the issuer's public offering.
  • [F2]Shares are owned by John C.K. Milligan Revocable Trust U/A 08/10/2009, as amended.
  • [F3]Shares are owned by the Milligan Irrevocable Nonexempt Trust - 2014. These securities are held in a trust for the benefit of the reporting person's spouse and children. The reporting person disclaims beneficial ownership of these securities and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Issuer

TherapeuticsMD, Inc.

CIK 0000025743

Entity typeother

Related Parties

1
  • filerCIK 0001532230

Filing Metadata

Form type
4
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 5:03 PM ET
Size
6.9 KB